NewLeaf Symbiotics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

newleafsym.com

Total Raised

$113.4M

Investors Count

14

Deal Terms

2

NewLeaf Symbiotics Funding, NewLeaf Symbiotics Valuation & NewLeaf Symbiotics Revenue

11 Fundings

NewLeaf Symbiotics's latest funding round was a Debt - IV for $10M on December 13, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/13/2021

Debt - IV

$10M

Undisclosed Investors

0

FY undefined

1

12/1/2020

Series D - II

$22M

0

FY undefined

2

4/15/2020

Loan

$0.68M

0

FY undefined

2/24/2020

Series D

$99M

0

FY undefined

10

1/8/2020

Debt - III

$99M

0

FY undefined

10

Date

12/13/2021

12/1/2020

4/15/2020

2/24/2020

1/8/2020

Round

Debt - IV

Series D - II

Loan

Series D

Debt - III

Amount

$10M

$22M

$0.68M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

2

10

10

NewLeaf Symbiotics Deal Terms

2 Deal Terms

NewLeaf Symbiotics's deal structure is available for 2 funding rounds, including their Series B from September 15, 2014.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

NewLeaf Symbiotics Investors

14 Investors

NewLeaf Symbiotics has 14 investors. RockPort Capital Partners invested in NewLeaf Symbiotics's Series D - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/9/2013

12/1/2020

5
Series A, Series B (2014), Series C (2017), Series D (2020), Series D - II (2020)

Kevin Kopczynski

Venture Capital

Massachusetts

9/15/2014

12/1/2020

4
Series B, Series C (2017), Series D (2020), Series D - II (2020)

John Pasquesi

Private Equity

California

9/7/2017

12/1/2020

3
Series C - II, Series D (2020), Series D - II (2020)

Venture Capital

Illinois

00/00/0000

00/00/0000

Leaps by Bayer

Subscribe to see more

Corporate Venture

Germany

00/00/0000

00/00/0000

Koch Agronomic Services

Subscribe to see more

Corporation

Kansas

First funding

1/9/2013

9/15/2014

9/7/2017

00/00/0000

00/00/0000

Last Funding

12/1/2020

12/1/2020

12/1/2020

00/00/0000

00/00/0000

Investor

Leaps by Bayer

Koch Agronomic Services

Rounds

5
Series A, Series B (2014), Series C (2017), Series D (2020), Series D - II (2020)
4
Series B, Series C (2017), Series D (2020), Series D - II (2020)
3
Series C - II, Series D (2020), Series D - II (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Kevin Kopczynski

John Pasquesi

Type

Venture Capital

Private Equity

Venture Capital

Corporate Venture

Corporation

Location

Massachusetts

California

Illinois

Germany

Kansas

NewLeaf Symbiotics Acquisitions

1 Acquisition

NewLeaf Symbiotics acquired 1 company. Their latest acquisition was Intuitive Genomics on December 06, 2013.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/6/2013

$99M

Acquired

1

Date

12/6/2013

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.